Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial77

File Visits

Downloads
7415-31389.pdf27

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial38

Number of downloads in the range

Downloads
7415-31389.pdf5

Views

Views
June 20259
July 202516
August 20251
September 20256
October 20252
November 20254
December 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • June 2025
    0
  • July 2025
    0
  • August 2025
    0
  • September 2025
    1
  • October 2025
    0
  • November 2025
    4
  • December 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil12
Singapore9
United States5
Germany2
Chile2
Canada1
Ecuador1
Finland1
United Kingdom1
Morocco1
 

Top countries by downloads

Downloads
United States4
Finland1
 

Top cities views

Views
Rio de Janeiro2
Aachen1
Ariquemes1
Averill Park1
Cafelândia1
Camaragibe1
Dallas1
Garibaldi1
Guayaquil1
Juazeiro do Norte1
 

Top cities by downloads

Downloads